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OBJECTIVE
To determine the frequency of cardiac abnormalities and
its natural history in children perinatally exposed to HIV-1.
METHODS
Eighty-four children exposed to HIV-1 were evaluated
by serial clinical, electrocardiographic (ECG), and Doppler-
echocardiographic (ECHO) examinations.
RESULTS
Group I – (seroreversion) - 43 children (51.2%).
Absence of clinical abnormalities. ECG:  incomplete right
bundle branch block (RBBB) – 5 cases. ECHO: atrial
septal defect (ASD) and ventricular septal defect (VSD) –
1 case each. Group II – 41 HIV-infected children (48.8%),
of whom 51.2% were found to have cardiac
abnormalities. Asymptomatic or mildly symptomatic
children without immunosuppression: no clinical and
echocardiographic abnormalities; ECG: incomplete right
bundle branch block (RBBB) – (2 cases). Children with
moderate and severe symptoms and immunological
impairment: the following abnormalities were found: 1)
clinical (31.7%)-isolated tachycardia (1 case), congestive
heart failure (12 cases). 2) electrocardiographic (43.9%)-
sinus tachycardia associated with other abnormalities (10
cases), incomplete right bundle branch block (5 cases),
left anterior hemiblock (1 case), right anterior hemiblock
(1 case), changes in ventricular repolarization (11 cases),
right ventricular overload (2 cases), left ventricular
overload (1 case), right QRS axis deviation (1 case), and
arrhythmias (3 cases). 3) echocardiographic (26.8%)-
dilated cardiomyopathy (5 cases), pericardial effusion with
tamponade (2 cases), pulmonary hypertension (2 cases),
and mitral valve prolapse (1 case).
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CONCLUSION
Cardiac involvement was a characteristic of the HIV-
infected group. Higher prevalence of abnormalities was
found among children belonging to the most advanced
clinical and immunological category. The most commonly
observed clinical, electrocardiographic and
echocardiographic findings were congestive heart failure
(CHF), changes in ventricular repolarization, and dilated
cardiomyopathy, respectively. The latter was reversible in
one case. Electrocardiogram changes were significantly
more frequent than clinical and echocardiographic changes.
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It has been twenty years since human immunode-
ficiency virus type I (HIV-1) was isolated, yet the cure for
acquired immunodeficiency syndrome (AIDS) is still not
a reality.  Despite the improvement in survival and quality
of life of HIV-1-infected patients, AIDS remains a serious
public health problem. Since the outbreak of the
pandemic, more than 42 million people have been
infected worldwide, with sixteen thousand new cases daily.
In Brazil, over 500,000 cases were reported, and half of
the patients have already died. The incidence of infected
women has greatly increased during the last twenty years
due to the current predominance of heterosexual
transmission, thus raising the prevalence of the disease
in pregnant women from 1% to 5%. Accordingly, the
number of perinatally infected children now accounts for
3.5% of all reports.1
AIDS is a systemic, infectious disease characterized
by immunosuppression, which predisposes infected
individuals to both opportunistic infections and neoplasias.
It is progressive in nature and may impair the
cardiovascular apparatus in multiple ways. The prevalence
of cardiac abnormalities seems to be underestimated both
in the adult and pediatric population. Most studies
conducted to date suggest values between 40% and 70%,
if electrocardiogram (ECG) and Doppler echocardiogram
(ECHO) findings are included in addition to clinical
findings. Autopsy studies show a high prevalence of
cardiac abnormalities.  In pathological studies, about 50%
of HIV-1-infected individuals without cardiovascular
symptoms are found to have interstitial lymphocytic
myocarditis. This figure rises to 83% in individuals who
develop congestive heart failure (CHF).2-11 The mechanism
by which the heart is injured in patients with AIDS remains
unclear. Childhood mortality due to cardiac complications
ranges from 1% to 9%.2,4,8,10,12-23
The ever-increasing number of children born to HIV-
positive mothers, coupled with the complex
etiopathogenesis of heart involvement and the need for
further understanding of the natural history of clinical
cardiac manifestations during childhood, led us to study
children exposed perinatally to HIV-1.  This is an eight-
year clinical, electrocardiographic, and echocardiographic
follow-up study.
METHODS
From July 1996 to July 2004, following approval by
the Institutional Research Ethics Committee (filed under
nº 089/96), eighty-four children perinatally exposed to
HIV-1 were prospectively studied. Thirty-nine were girls
(46.4%) and 45 were boys (53.6%), ages ranging for
both from thirteen days to thirteen years old.
All children were Brazilian and resident in São Paulo.
Inclusion criteria were the following: children born to HIV-
positive mothers and, thus, perinatally exposed to HIV-1
(via transplacental, labor or breastfeeding routes); less
than 13 years old at the time of the baseline cardiac
evaluation; regular follow-up at the pediatric cardiology
outpatient clinic  with a minimum of two clinical and
electrocardiographic evaluations and one
echocardiographic study. Only children whose legal
guardians agreed with their participation and provided a
written “Informed Consent” were enrolled in the study.
Clinical and immunological status of the infected
children was defined according to the Centers for Disease
Control24 “Revised classification system for human
immunodeficiency virus infection in children less than
13 years of age”, as shown in table I.
Diagnosis was made using Elisa and agglutination
serological assays and confirmed by quantification of
plasma RNA viral load, evaluated in number of copies by
the NASBA method (Nucleic acid sequence-based
amplification) (Organon Teknika).  The lower detection
limit of the assay was 80 copies/mL. CD4 T-lymphocyte
counts were determined using flow cytometry Laboratory
follow-up and included Elisa assay, plasma viral load,
and CD4 T-lymphocyte count.
A complete cardiac evaluation was performed.  Heart
failure was diagnosed on the basis of standard clinical
criteria for children.25,26
No sedation was used during ECG recordings.
Electrocardiograms were performed using Hewlett Packard
PageWriter 100, USA; ECAFIX ECG-6 – 023236, Brazil,
and Dixtal DX-2500, Brazil, equipment. The guidelines
set by the Committee on Electrocardiography of the
American Heart Association were followed.27Standard 12-
lead ECGs were used.  The following variables were
evaluated: heart rate (HR), rhythm, P wave (in lead II),
N A B C
Signs/symptoms Absent Signs/symptoms Mild Signs/symptoms Moderate Signs/symptoms Severe
1
No suppression N1 A1 B1 C1
2
Moderate suppression N2 A2 B2 C2
3
Severe Suppression N3 A3 B3 C3
Clinical CategoriesImmunological
Categories
Table I - Revised classification system for HIV-infection in children less than 13 years of age issued by the Centers for Disease Control (CDC) - 1994
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Table II - Children from group II according to the
initial and final clinical classification
Initial Final
Group n % n %
II-A 18 43.9 11 26.8
II-B 12 29.3 11 26.8
II-C 11 26.8 19 46.3
Total 41 100.0 41 100.0
Group II-A (N + A): N1+ N2 + A1+ A2 + A3; group II-B: B1+ B2
+ B3 group II-C: C1+ C2 + C3
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Fig. 1 - Ten-year-old, AIDS C2. Dilated cardiomyopathy. a) Two-dimensional ECHO:  heart in diastole - apical four-chamber view showing left
chamber dilation; b) Two-dimensional ECHO, parasternal cross-sectional view (figure 1A) and M-mode ECHO (figure 1B): left ventricle dilation.
LVDd = 62, LVDs = 51, ∆D% = 17
PR interval (in lead II), QRS complex, ST segment, T
wave,  QT interval corrected for heart rate  (in lead II).
All ECGs were analyzed by two different observers.
Electrocardiographic analysis was performed taking as
reference the normal ECG standards for infants and
children set by Davignon et al.28
Doppler echocardiogram was performed using different
echocardiographs currently available   equipped with 3,5
and 5 MHz transducers capable of producing B-mode
and M-mode images. Spectral Doppler and color flow
imaging were used for measurement of blood flow velocity.
The use of sedatives was avoided. The guidelines set by
the American Society of Echocardiography were
followed.29 Left ventricular function was estimated by
ejection fraction (cube method) and fractional shortening
[Dd – Ds/Dd) x 100].  Snider et al.’s30 criteria for normality
in children were employed, as well as reference values
issued by Escola Paulista de Medicina, UNIFESP, resulting
from the fifteen-year cumulative experience of its
Echocardiographic Department (unpublished data).
Dilated cardiomyopathy was defined as left ventricular
dysfunction characterized by a diffuse decrease in
myocardial contractility, with fractional shortening below
normal limits (< 28%), followed by left ventricular
enlargement, with diastolic diameter above normal values
for the weight range.10, 31,32
The results were assessed by means of non-parametric
tests, the nature of the studied variables considered. The
following tests were performed: 1) Kappa test,33 to
evaluate the agreement of clinical and immunological
classification of HIV-infection noted in the first and second
examination; 2) McNemar test, 34  to study the
disagreement observed above and below the diagonal in
Kappa test; 3) Cochran G-test,35 to compare
simultaneous clinical, electrocardiographic, and
echocardiographic changes; 4) chi-square test, 36 for 2
x N tables, to compare groups refarding the presence of
cardiac abnormalities.  Significance level for rejection of
the null hypothesis was set at 0,05 or 5% in all tests.
RESULTS
The 84 children exposed to HIV-1 were divided in two
groups: Group I: 43 children (51.2%) who seroreverted
(SR), i.e., they were exposed to HIV-1 but did not get
infected. Mean age at the first and last visit was 6.8
months and 34.1 months, respectively. Group II: 41
infected children (48.8%). Mean age at the first and last
visit was 40.8 months and 76.4 months, respectively.
Distribution of infected children according to initial and
final clinical classification is shown in Table II.
Among the groups of children infected with HIV-1, 14
children (34.1%) changed clinical group and 6 children
(17.6%) changed immunological group between the
beginning and end of study, showing significant clinical
and immunological worsening.
Group I (SR) – Absence of clinical abnormalities in all
cases. ECG:  incomplete right bundle branch block in 5
children (11.6%). ECHO: small ostium secundum atrial
septal defect  (1 case), and small perimembranous
ventricular septal defect  (1 case).  These were the only
congenital heart diseases found in the study (2/84 or
2.4%).
Group II – Of the 41 infected children, 51.2%
developed some kind of cardiac abnormality. Fourteen
children experienced clínical worsening in terms of the
HIV-1 infection. Among these, 10 (71.4%) had cardiac
abnormalities; electrocardiographic changes were
Fig. 1A Fig. 1B
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Fig. 2A
Fig. 2B
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Fig. 2 - Nine-year-old, AIDS B3.  Bacterial pericarditis. A) ECG -
acute phase: diffuse changes in ventricular repolarization with ST-
segment elevation (arrow); b) ECG one year later; reversion of the
changes in ventricular repolarization
significantly more frequent (9 cases) than either clinical
(4 cases) or echocardiographic changes (3 cases).
Of the 41 infected children, 13 (31.7%) developed
clinical cardiac changes, one of whom had tachycardia
as an isolated symptom. The other 12 patients developed
CHF associated with the following etiologies: dilated
cardiomyopathy (5/41 – 12.2%) (fig. 1); pericardial
effusion with cardiac tamponade caused by bacterial
pericarditis (2/41 – 4.9%) (figs. 2 e 3); pulmonary
hypertension secondary to chronic lung disease (2/41 –
4.9%) (fig. 4);  respiratory infection; sepsis; and anemia:
3/41 (7.3%). No changes in Group II-A were found; 2
cases occurred in Group II-B and 11 cases (84.6%) in
Group II-C.
Of the 41 infected children, 20 (48.8%) developed
electrocardiographic changes.
 In group II-A only 2 cases of incomplete right bundle
branch block occurred. In group II-B, the following five
changes were observed: incomplete right bundle branch
block, left anterior hemiblock (1 case), right QRS axis
deviation, right ventricular overload, and junctional rhythm
(one case each). Most changes (13 cases – 65%) occurred
in group II-C, distributed as follows: 4 cases of sinus
tachycardia with change in ventricular repolarization; 3
cases of incomplete right bundle branch block; 1 case
each of isolated sinus tachycardia, isolated change in
ventricular repolarization, alternating sinus and junctional
bradycardia associated with change in ventricular
repolarization, change in ventricular repolarization with
prolonged QTc, right ventricular overload, and left
ventricular overload. One child developed ventricular
arrhythmia with frequent bigeminal extrasystoles and
periods of ventricular tachycardia.
Of the 41 infected children, 11 (26.8%) developed
echocardiographic changes: no changes in Group II-A; 3
changes in Group II-B and 8 changes in Group II-C. The
following changes were found in Group II-B: pulmonary
hypertension with RV dysfunction and tricuspid
insufficiency; mild isolated mitral insufficiency; and
pericardial effusion with cardiac tamponade, one case of
each. Changes in Group II-C were: five cases of LV
dysfunction and dilation, three cases of mild/moderate
secondary mitral insufficiency; one case each of infectious
pericardial effusion with tamponade, moderate pulmonary
hypertension with mild tricuspid insufficiency and mitral
valve prolapse with mild mitral insufficiency.
Children with dilated cardiomyopathy were clinically
highly compromised. They suffered from severe protein-
calorie malnutrition (PCM), recurrent respiratory infection,
and chronic anemia. Three of them progressed to sepsis
and death. Of the children who developed dilated
cardiomyopathy, two are still alive. One manifested the
disease early on, with increased severity and multiple
organ damage associated with AIDS.  Now, at 9 years
old, however,  this child is clinically stable and receiving
antiretroviral therapy, with no CHF signs or symptoms
and normal ECG and ECHO.  The other is thirteen years
old, and although cardiomyopathy have not been reverted,
is stable and under treatment for CHF (fig. 1). This child
underwent cardiac catheterization with myocardial biopsy,
which was negative for myocarditis.
Both cases of bacterial pericarditis with effusion and
cardiac tamponade were managed using
pericardiocentesis and antibiotic therapy. Valvular
insufficiencies were common and usually secondary to
left and/or right ventricular dilation, with mitral
insufficiency predominating.
Infected children who developed cardiac abnormalities
belonged to moderate and, especially, severe immuno-
suppressed groups.  Eight children, 19.5% of those
infected, died during the cardiac follow-up, and all of them
belonged to group II-C, category C3. They were severely ill
and infected with opportunistic microorganisms.
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Fig. 3 - Two-year-old, AIDS C2. Pyopericardium with cardiac tamponade. a)  Pre-drainage chest x-ray (PA): severe global cardiomegaly with a globe-
shaped cardiac contour; b) post-drainage chest x-ray (PA): cardiac area of normal dimension
DISCUSSION
Congestive heart failure, dilated cardiomyopathy,
pericardial effusion with or without tamponade,
arrhythmias, marantic and infective endocarditis and,
more rarely and still controversial, congenital heart
diseases, are cardiac abnormalities that can result from
the acquired immunodeficiency syndrome.4,10,15,20-22,37-40
Cardiac studies performed on HIV-1 infected children
provided  greater understanding of the evolution and
clinical management of the diseased heart. However, in
the reviewed literature, we found no longitudinal study
correlating cardiac changes and progression of the
infection, either clinically or immunologically.
Analysis of the clinical evolution of the 41 infected
children showed that cardiac changes occurred in the
AIDS groups with moderate clinical and immunological
signs and symptoms. Cardiac manifestations of HIV
infection were significantly more frequent in the groups
whose patients were in advanced stages of the disease.
Heart failure was the most frequent clinical finding, most
often caused by dilated cardiomyopathy, and a finding
unique to category C, particularly C3. These results are
similar to those found in the literature. Cardiac changes
frequency increases as the disease progresses, and early
detection of these changes usually depends on
complementary examinations, such as electrocardiograms
and echocardiograms.4-42 Unlike the results obtained in
this study, in the experience of Luginbuhl et al.,20 Lipshultz
et al.,23 and Della Negra et al.,43 tachycardia was the
most frequent and early sign of clinical manifestations.
According to our experience, in all but one case
tachycardia occurred only at the time of cardiac
decompensation.
The etiopathogenesis of myocardial dysfunction in
AIDS, however, remains unclear. Even though HIV has
already been isolated from myocardial cells derived from
endomyocardial biopsies and autopsy specimens, in which
non-specific lymphocytic myocarditis is a common finding,
the direct cytolytic effect of HIV is debatable.  Biopsy
was performed only in one case, and was found to be
negative. Cardiac damage is believed to be multifactorial,
meaning that several elements work together to affect
the heart adversely, leading to functional and anatomical
changes with a strong autoimmune component. In
addition to the immunological aspects, among the factors
involved in the genesis of cardiac dysfunction are the co-
infections with cardiotropic viruses, such as
citomegalovirus, Epstein-Bar, and cocksackie B, anemia,
PCM, autonomic dysfunction, and trace element
deficiency, such as selenium and L-carnitine, vitamin A
deficiency, toxic response to antiretroviral agents,
pentamidine and sulfamethoxazole with trimethoprim,
oxidative stress, and genetic susceptibility.8,10,18,37,41,44-55
Pyopericardium and cardiac tamponade occurred in 2
cases (4.9%) in this study, but these are serious cardiac
complications and clinical emergencies that could have
resulted in death. Prevalence of pericarditis with effusion
in the literature is about 22%; however autopsy findings
put this as higher.56 Approximately 30% of adults infected
with HIV but without cardiac symptoms have pericardial
damage. This figure rises to 48% in symptomatic patients.
Few cases of cardiac tamponade in children with infectious
effusion have been reported in the literature.22,37,57
Similar to the clinical course of HIV-infected patients,
electrocardiographic and echocardiographic changes were
more common in categories with more advanced clinical
and immunological involvement. In this study, ventricular
repolarization change was the most significant
electrocardiographic abnormality. Its onset was
progressive and observed in the most severe clinical and
immunological groups. According to the literature, changes
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Fig. 4 - Eight-year-old, AIDS B2. Pulmonary hypertension secondary
to chronic lung disease. Chest x-ray (PA): enlargement of right
chambers, bulging of the middle arch and heterogeneous hypolucent
pulmonary images due to infection; b) ECG: severe right atrial and
ventricular overload; c) Two-dimensional ECHO - parasternal cross-
sectional axis view: enlargement of pulmonary artery trunk (AP); ECHO/
Doppler - Pulmonary artery pressure estimated at 87 mm Hg
in ventricular repolarization are common findings in ECGs
of children with AIDS in advanced clinical and
immunological stage.4,10,20,22
The incidence of arrhythmia in this study was 7.3%,
a low incidence compared to that reported in the literature,
as only electrocardiogram was used.58-61 Incomplete right
bundle branch block was the most frequent manifestation
in infected children (7 cases – 17%). This conduction
disturbance was the earliest of all changes, since it was
the only one observed in the group of asymptomatic
children. However, the small size of the sample did not
allow us to prove that this finding is clinically relevant in
infected children, because normal children may also have
this kind of change. Incomplete right bundle branch block
was a common finding in other studies as well.4,43
Echocardiographic studies in HIV-infected children
and adults show a high prevalence of cardiac changes
even in the absence of clinical signs and symptoms.
3,8,10,16,20,21-22 Nevertheless, in this series, no
echocardiographic changes were found in clinically
asymptomatic or mildly symptomatic children, and thus
similar to the course of the seroreverted children.
Echocardiographic manifestations were detected in
children with moderate signs and symptoms and
moderate immunosuppression, and predominated in the
highly compromised clinical and immunological groups.
Dilated cardiomyopathy was the most common finding
of the study, being reversible in one patient, a striking
case due to its severe and premature nature.62 This was
the first reported case of reversibility of a severe case
during childhood with long-term cardiac follow-up. The
results of the multicentric study P2C2, involving 196 HIV-
infected children23, showed that LV dysfunction and
dilation are common abnormalities that can be also
subclinical. The authors found echocardiographic
changes in all symptomatic children (88%).
As for pulmonary hypertension in children with AIDS,
despite the high incidence of respiratory compromise,
the literature is scant63,64. In this study, 2 patients
developed severe pulmonary hypertension and cor
pulmonale secondary to chronic pulmonary infection.
In summary, this longitudinal study showed a clear
correlation between AIDS and progressive cardiac
compromise, with mortality of 19.5% at the advanced
stage. Also, in the eight-year follow-up, no cardiac changes
were found in children exposed to but not infected with
HIV. Similar result has not been reported in the literature.
CONCLUSIONS
Clinical, electrocardiographic, and echocardiographic
changes in children exposed to HIV-1 were a charac-
teristic of the infected group (AIDS), manifested in a
progressive form and become prominent in the clinical
and immunological advanced stages of the disease. They
were more frequent in children who switched clinical and
immunological grouping.
From a clinical perspective, CHF was the most common
manifestation, as well as change in ventricular
repolarization was the most frequent ECG finding. Dilated
cardiomyopathy was the most frequent echocardiographic
change, and was found to be characteristic of the severe
clinical and immunological stages of the disease. One
case of reversion occurred, clinically, electrocar-
diographically and echocardiographically. Pericardium
with tamponade was a clinical emergency.
Children exposed to but not infected with HIV-1 did
not develop any form of cardiovascular disease, a
valuable and highly reassuring finding for the families
of those involved.
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